Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+47.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$24.6B
AUM Growth
-$4.32B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,158
New
Increased
Reduced
Closed

Top Buys

1
+$417M
2
+$152M
3
+$74.2M
4
QCOM icon
Qualcomm
QCOM
+$39.4M
5
MRVL icon
Marvell Technology
MRVL
+$24.7M

Top Sells

1
+$647M
2
+$341M
3
+$243M
4
LRCX icon
Lam Research
LRCX
+$194M
5
NVDA icon
NVIDIA
NVDA
+$191M

Sector Composition

1 Technology 48.84%
2 Financials 8.23%
3 Consumer Discretionary 5.72%
4 Healthcare 3.78%
5 Industrials 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JELD icon
1051
JELD-WEN Holding
JELD
$159M
$82.6K ﹤0.01%
66,623
-12,410
WVE icon
1052
Wave Life Sciences
WVE
$1.11B
$75.5K ﹤0.01%
10,420
-1,137
AQST icon
1053
Aquestive Therapeutics
AQST
$507M
$61.9K ﹤0.01%
14,919
-10,507
ARKO icon
1054
ARKO Corp
ARKO
$848M
$57.1K ﹤0.01%
+10,270
KEEL
1055
Keel Infrastructure Corp
KEEL
$3.07B
$43.6K ﹤0.01%
22,373
-3,415
BTBT icon
1056
Bit Digital
BTBT
$562M
$15.9K ﹤0.01%
12,111
-2,890
GNK icon
1057
Genco Shipping & Trading
GNK
$1.07B
$13.6K ﹤0.01%
605
-58
ACM icon
1058
Aecom
ACM
$9.11B
– –
-2,226
AI icon
1059
C3.ai
AI
$1.45B
– –
-10,419
ALLY icon
1060
Ally Financial
ALLY
$13B
– –
-4,711
AMBA icon
1061
Ambarella
AMBA
$2.88B
– –
-3,310
AMLX icon
1062
Amylyx Pharmaceuticals
AMLX
$1.5B
– –
-17,673
AMPH icon
1063
Amphastar Pharmaceuticals
AMPH
$871M
– –
-7,682
ANIP icon
1064
ANI Pharmaceuticals
ANIP
$1.83B
– –
-2,851
APLD icon
1065
Applied Digital
APLD
$11.1B
– –
-8,912
ARVN icon
1066
Arvinas
ARVN
$488M
– –
-17,650
AVDL
1067
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-10,884
HIVE
1068
HIVE Digital Technologies
HIVE
$998M
– –
-10,806
HL icon
1069
Hecla Mining
HL
$9.99B
– –
-11,261
HRMY icon
1070
Harmony Biosciences
HRMY
$1.9B
– –
-5,954
HROW icon
1071
Harrow
HROW
$1.27B
– –
-4,657
HUT
1072
Hut 8
HUT
$12.8B
– –
-4,924
IMRX icon
1073
Immuneering
IMRX
$275M
– –
-130,742
INDV icon
1074
Indivior Pharmaceuticals
INDV
$4.53B
– –
-6,596
INVA icon
1075
Innoviva
INVA
$1.67B
– –
-11,339
41 42
43
44 45